COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 07:00, il y a 1 année 9 mois NORMA Group completes a challenging financial year 2024 with a stable level of profitability NORMA Group successfully concludes 2024 with stable profitability. Preliminary figures show sales of EUR 1.2 billion, adjusted EBIT at EUR 92.3 million, and strong cash flow. Divestment of Water Management business initiated Market Challenges Profitability 2024 Financial Results NORMA Group Divestment Process
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 07:00, il y a 1 année 9 mois BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE BioVersys advances BV500 NTM program with continued support from CF AMR Syndicate, developing therapies for NTM lung disease in CF patients. Company focuses on antibacterial products against MDR bacteria BioVersys BV500 NTM Program CF AMR Syndicate NTM Lung Disease MDR Bacteria
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 07:00, il y a 1 année 9 mois TUI Group: 10th consecutive quarter of Und. EBIT growth – Hotels, Cruises and TUI Musement driving improvement in FY25 Q1 TUI Group reports 10th consecutive quarter of underlying EBIT growth in FY25 Q1, driven by Hotels, Cruises, and TUI Musement. Q1 revenue up +13% to €4.9bn. Market + Airline segment shows 31% lower underlying EBIT due to investments for summer season Revenue Growth Underlying EBIT TUI Group FY25 Q1 Market + Airline
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 07:00, il y a 1 année 9 mois Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics obtains European Patent Office grant for RLF-TD011, securing patent protection for epidermolysis bullosa treatment. Company advances wound care solution Relief Therapeutics European Patent Office Epidermolysis Bullosa Wound Treatment RLD-TD011
COMMUNIQUÉ RÉGLEMENTÉ publié le 11/02/2025 à 07:00, il y a 1 année 9 mois Biophytis dévoile ses perspectives stratégiques de l’année 2025 Biophytis dévoile ses perspectives stratégiques pour l’année 2025, incluant le lancement de nouveaux programmes cliniques et des collaborations clés dans le domaine des maladies liées à l'âge Stratégie Biophytis Partenariats Développement Clinique Maladies Liées À L'âge
COMMUNIQUÉ RÉGLEMENTÉ publié le 11/02/2025 à 07:00, il y a 1 année 9 mois Biophytis unveils its outlook strategies for 2025 Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements Biophytis Clinical Development BIO101 Obesity Strategic Outlook
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 06:58, il y a 1 année 9 mois Board member Christina Johansson passes away Emmi Group announces the passing of Board member Christina Johansson, a valued financial expert and Chairwoman of the Audit Committee Board Member Emmi Group Audit Committee Financial Expert Christina Johansson
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 06:58, il y a 1 année 9 mois Décès de Christina Johansson, membre du Conseil d'administration Décès de Christina Johansson, membre du Conseil d'administration du groupe Emmi. Annonce officielle avec condoléances et hommage au travail accompli Conseil D'administration Décès Emmi Christina Johansson Condoléances
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 06:57, il y a 1 année 9 mois ALSO enters US - First step: Cloud ALSO Holding AG expands into the US market with a focus on cloud solutions, leveraging the country's large economy and high cloud usage. The company aims to drive cloud migrations, enhance cybersecurity, and promote AI adoption Expansion US Market ALSO Holding AG Cloud Solutions IT Services
COMMUNIQUÉ DE PRESSE publié le 11/02/2025 à 01:00, il y a 1 année 9 mois Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study Onco-Innovations Limited introduces exclusive PNKP inhibitors to enhance sensitivity of cancer cells to radiation, potentially revolutionizing targeted cancer treatments Colorectal Cancer Radiation Therapy PNKP Inhibitors Onco-Innovations Limited Cancer Cells
Publié le 19/11/2026 à 08:30, il y a 52 minutes Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Publié le 19/11/2026 à 08:30, il y a 52 minutes Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité
Publié le 19/11/2026 à 08:00, il y a 1 heure 22 minutes EXOR VA RENFORCER SA PARTICIPATION DANS BIOMÉRIEUX
Publié le 19/11/2026 à 07:30, il y a 1 heure 52 minutes Gimv investeert in SpiraTec, specialist in automatisering en digitale transformatie in de procesindustrie
Publié le 19/11/2026 à 04:25, il y a 4 heures 57 minutes Predictiv AI Announces Appointment of Interim Chief Executive Officer
Publié le 18/11/2026 à 23:30, il y a 9 heures 52 minutes Jericho Energy Ventures Provides Update on Oil and Gas Joint Venture Credit Facility
Publié le 18/11/2026 à 23:30, il y a 9 heures 52 minutes Presentation to Swiss Mining Institute Conference
Publié le 18/11/2026 à 21:15, il y a 12 heures 7 minutes Sparta Capital Ltd. Announces Resumption of Trading
Publié le 18/11/2026 à 15:30, il y a 17 heures 52 minutes Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
Publié le 19/11/2026 à 09:05, il y a 16 minutes Novelis invests in waste heat recovery to help power Nachterstedt recycling plant
Publié le 19/11/2026 à 09:05, il y a 16 minutes Original-Research: SMAG Mobile Antenna Masts AG (von NuWays AG): BUY
Publié le 19/11/2026 à 08:05, il y a 1 heure 16 minutes ROHM Develops TP-PFC Controller IC for GaN High-frequency Switching